Cerephex to seek FDA clearance for fibromyalgia treatment

06/3/2010 | Medical Devices Today

Cerephex said it will submit an application with the FDA within a year to seek 510(k) clearance for NeuroPoint, a non-invasive device that delivers cortical stimulation to treat fibromyalgia. The company plans to schedule a July meeting with the agency to ask for comments on its two-year study data.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX